HomeGreater Than Icon
Remedium Lifecare LtdGreater Than Icon
Remedium Lifecare Ltd Financials
Company Logo

Remedium Lifecare Ltd Financial Statement

Remedium Lifecare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue79.59
Operating Expense77.31
Net Profit1.64
Net Profit Margin2.06
Earning Per Share0.16
EBIDTA2.28
Effective Tax Rate27.63

Remedium Lifecare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual4,041.71
Operating Expenses Annual4,008.40
Operating Profit Annual54.38
Interest Annual3.87
Depreciation0.06
Net Profit Annual32.73
Tax Annual17.72

Remedium Lifecare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning21.86
Cash Flow from Operations-74.16
Cash Flow from InvestingTBA
Cash Flow from Financing53.83
Cash Flow at the End1.52

Remedium Lifecare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)1.37
PBIT Margin (%)1.37
PBT Margin (%)1.08
Net PROFIT Margin (%)0.81
Return On Networth / Equity (%)122.77
Return On Networth /Employed (%)99.50
Return On Assets (%)58.95
Total Debt / Equity (X)1.08
Asset Turnover Ratio (%)72.80

Remedium Lifecare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.05
Total Current Assets Annual1,947.85
Non Current Assets Annual0.07
Total Shareholders Funds Annual42.96
Total Assets Annual1,947.92

Remedium Lifecare Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 4, 2024, Remedium Lifecare Ltd has a market capitalization of 1,093.68 Cr. Value Research classifies it as a Small-Cap company.
No, Remedium Lifecare Ltd is not debt-free with a debt-to-equity ratio of 1.34.
In FY 2023 , Remedium Lifecare Ltd recorded a total revenue of approximately 4,041.71 Cr marking a significant milestone in the company's financial performance.
Remedium Lifecare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.6% and 1.0% annually, respectively..
Remedium Lifecare Ltd's current PE ratio is 33.42.
Remedium Lifecare Ltd's ROCE averaged 52.6% from the FY ending March 2022 to 2024, with a median of 54.0%. It peaked at 70.6% in March 2023, reflecting strong capital efficiency over the period..
Remedium Lifecare Ltd's latest EBIT is Rs. 54.32 Cr, surpassing the average EBIT of Rs. 21.09 Cr over the 5 years..